Valion Bio outlines three-part strategy under new interim CEO
Go back to Valion Bio outlines three-part strategy under new interim CEO| (NASDAQ: VBIO) | Delayed: 1.12 -0.07 (5.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.19 | 52 Week High | $1.84 | |||
| Open | $1.20 | 52 Week Low | $0.61 | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.10 | EPS | $0.00 | |||
| Volume | 184,935 | |||||



